TOLMAR is a venture capital fund that supports early-stage biotech companies. Specializing in new medical technologies, they offer financial backing primarily to Series A startups. One notable investment is DelSiTech. TOLMAR aims to advance medical research and development by supporting businesses with significant healthcare impact potential.